FALKMAN , Lovisa et al. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. Upsala Journal of Medical Sciences, [S. l.], v. 129, n. S1, p. e10660, 2024. DOI: 10.48101/ujms.v129.10660. Disponível em: https://ujms.net/index.php/ujms/article/view/10660. Acesso em: 14 nov. 2026.